DWAM
RMD icon

Duncan Williams Asset Management’s ResMed RMD Stock Holding History

Duncan Williams Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767K Sell
3,934
-138
-3% -$28.6K 0.17% 75
2026
Q1 		$914K Sell
4,072
-379
-9% -$94.4K 0.25% 60
2025
Q4 		$1.17M Sell
4,451
-309
-6% -$79K 0.29% 48
2025
Q3 		$1.3M Buy
4,760
+142
+3% +$38.8K 0.37% 40
2025
Q2 		$1.19M Buy
4,618
+749
+19% +$179K 0.38% 44
2025
Q1 		$866K Buy
3,869
+471
+14% +$110K 0.31% 55
2024
Q4 		$777K Sell
3,398
-5
-0.1% -$1.2K 0.31% 57
2024
Q3 		$831K Buy
3,403
+159
+5% +$35.5K 0.46% 43
2024
Q2 		$621K Buy
3,244
+420
+15% +$85.2K 0.52% 36
2024
Q1 		$559K Buy
+2,824
New +$517K 0.5% 36

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Duncan Williams Asset Management's RMD Position: Q2 2026 in Review

Duncan Williams Asset Management reduced its ResMed (RMD) stake by 3.4% in Q2 2026, selling an estimated $28.6K and leaving 3,934 shares worth $767K. The position accounts for 0.17% of the portfolio, ranked #75.

Duncan Williams Asset Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.3M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Duncan Williams Asset Management held 3,934 shares of ResMed worth $767K as of Q2 2026.
  • Duncan Williams Asset Management sold 138 ResMed shares in Q2 2026, an estimated $28.6K.
  • ResMed made up 0.17% of Duncan Williams Asset Management's portfolio in Q2 2026, its #75 holding.
  • Duncan Williams Asset Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Duncan Williams Asset Management's ResMed position peaked at $1.3M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.